Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care : A Randomized Clinical Trial using the Family Check-Up
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
This study evaluated acceptability, engagement in prevention, and efficacy of a primary care screening-and-referral-to-prevention program to reduce substance use in early adolescence. Screening tools were the Youth Risk Index and Transmissible Liability Index and prevention consisted of the Family Check-Up (FCU). Three hundred sixty-one 10- to 13-year-olds from low resource neighborhoods (85.9% African American; 52.4% female) screened "at risk" during primary care visits and were randomized to the FCU (n = 123) or usual care (n = 238). Screening was acceptable to parents and youths: nearly 95% of each rated it as important, about 90% of each were happy with or did not mind it, and only 2.4% of parents did not want their child to be screened at their next check-up. Of parents who had a chance to receive the FCU (or waitlist-control), 87.5% followed through with researchers while 93.5% who were offered FCU engaged in it. FCU efficacy primarily involved interactions such that youth with greater risk at baseline experienced larger benefits. At 12-month follow-up, FCU was associated with 11% reduced risk of initiating a new substance per substance that had been initiated before baseline; greater reductions in tolerance of deviance among those with higher tolerance of deviance at baseline; and a main effect of reduced anxiety, but no effect for conduct problems. Pediatric well-child check-up screening can identify high-risk youth before, or in the initial stages of, problematic SU; engage families in a preventive intervention; and reduce rates of substance use and related risk factors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
---|---|
Enthalten in: |
Research on child and adolescent psychopathology - 51(2023), 2 vom: 08. Feb., Seite 151-163 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Galán, Chardée A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adolescence |
---|
Anmerkungen: |
Date Completed 24.01.2023 Date Revised 02.08.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10802-022-00978-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM347236391 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM347236391 | ||
003 | DE-627 | ||
005 | 20231226033346.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10802-022-00978-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1157.xml |
035 | |a (DE-627)NLM347236391 | ||
035 | |a (NLM)36208361 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Galán, Chardée A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care |b A Randomized Clinical Trial using the Family Check-Up |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.01.2023 | ||
500 | |a Date Revised 02.08.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a This study evaluated acceptability, engagement in prevention, and efficacy of a primary care screening-and-referral-to-prevention program to reduce substance use in early adolescence. Screening tools were the Youth Risk Index and Transmissible Liability Index and prevention consisted of the Family Check-Up (FCU). Three hundred sixty-one 10- to 13-year-olds from low resource neighborhoods (85.9% African American; 52.4% female) screened "at risk" during primary care visits and were randomized to the FCU (n = 123) or usual care (n = 238). Screening was acceptable to parents and youths: nearly 95% of each rated it as important, about 90% of each were happy with or did not mind it, and only 2.4% of parents did not want their child to be screened at their next check-up. Of parents who had a chance to receive the FCU (or waitlist-control), 87.5% followed through with researchers while 93.5% who were offered FCU engaged in it. FCU efficacy primarily involved interactions such that youth with greater risk at baseline experienced larger benefits. At 12-month follow-up, FCU was associated with 11% reduced risk of initiating a new substance per substance that had been initiated before baseline; greater reductions in tolerance of deviance among those with higher tolerance of deviance at baseline; and a main effect of reduced anxiety, but no effect for conduct problems. Pediatric well-child check-up screening can identify high-risk youth before, or in the initial stages of, problematic SU; engage families in a preventive intervention; and reduce rates of substance use and related risk factors | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Adolescence | |
650 | 4 | |a Family Check-up | |
650 | 4 | |a Indicated prevention | |
650 | 4 | |a Primary care | |
650 | 4 | |a Screening | |
650 | 4 | |a Substance use | |
700 | 1 | |a Shaw, Daniel S |e verfasserin |4 aut | |
700 | 1 | |a O'Rourke, Flannery |e verfasserin |4 aut | |
700 | 1 | |a Reynolds, Maureen D |e verfasserin |4 aut | |
700 | 1 | |a Gill, Anne |e verfasserin |4 aut | |
700 | 1 | |a Bogen, Debra L |e verfasserin |4 aut | |
700 | 1 | |a Ridenour, Ty A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Research on child and adolescent psychopathology |d 2021 |g 51(2023), 2 vom: 08. Feb., Seite 151-163 |w (DE-627)NLM313132089 |x 2730-7174 |7 nnns |
773 | 1 | 8 | |g volume:51 |g year:2023 |g number:2 |g day:08 |g month:02 |g pages:151-163 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10802-022-00978-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 51 |j 2023 |e 2 |b 08 |c 02 |h 151-163 |